TET2 is Required to Suppress Mtorc1 Signaling Through Urea Cycle with Therapeutic Potential

Jing He,Mingen Lin,Xinchao Zhang,Ruonan Zhang,Tongguan Tian,Yuefan Zhou,Wenjing Dong,Yajing Yang,Xue Sun,Yue Dai,Yue Xu,Zhenru Zhang,Ming Xu,Qun-Ying Lei,Yanping Xu,Lei Lv

DOI: https://doi.org/10.1038/s41421-023-00567-7

IF: 38.079

2023-01-01

Cell Discovery

Abstract:Tumor development, involving both cell growth (mass accumulation) and cell proliferation, is a complex process governed by the interplay of multiple signaling pathways. TET2 mainly functions as a DNA dioxygenase, which modulates gene expression and biological functions via oxidation of 5mC in DNA, yet whether it plays a role in regulating cell growth remains unknown. Here we show that TET2 suppresses mTORC1 signaling, a major growth controller, to inhibit cell growth and promote autophagy. Mechanistically, TET2 functions as a 5mC “eraser” by mRNA oxidation, abolishes YBX1–HuR binding and promotes decay of urea cycle enzyme mRNAs, thus negatively regulating urea cycle and arginine production, which suppresses mTORC1 signaling. Therefore, TET2-deficient tumor cells are more sensitive to mTORC1 inhibition. Our results uncover a novel function for TET2 in suppressing mTORC1 signaling and inhibiting cell growth, linking TET2-mediated mRNA oxidation to cell metabolism and cell growth control. These findings demonstrate the potential of mTORC1 inhibition as a possible treatment for TET2-deficient tumors.